Silvant Capital Management »

Axsome Therapeutics shares owned by Silvant Capital Management

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Silvant Capital Management from 13F filings

Historical chart of Silvant Capital Management investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Silvant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Silvant Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $66k 270 244.77

More positions owned by Silvant Capital Management

NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Apple (AAPL)
Ge Vernova (GEV)
Ge Aerospace Com New (GE)
Meta Platforms Cl A (META)
Royal Caribbean Cruises (RCL)
Visa Com Cl A (V)
Arm Holdings Sponsored Ads (ARM)
Amazon (AMZN)
Teradyne (TER)
Netflix (NFLX)

View all positions for Silvant Capital Management

Top funds holding Axsome Therapeutics

BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Invesco
FMR
T. Rowe Price Associates
State Street Corporation
Geode Capital Management
Susquehanna International
Jane Street
Deep Track Capital
Two Sigma Investments
Franklin Resources
Wellington Management Company
D. E. Shaw & Co

View all funds holding Axsome Therapeutics